FDA biopharmaceutical drug approvals increase despite slower development time

The U.S. Food and Drug Administration has passed nearly twice as many biopharmaceutical drug approvals in the last 10 years than it did in the 1990s, a news release from the Tufts Center for the Study of Drug Development (CSDD) has indicated.  From 2000 to 2009, 65 biopharmaceutical drugs got the OK from the FDA. In comparison, the 1990s saw 39 approvals, while the 1980s had 13 approvals, according to the CSDD study. Click here to read the full article.